Literature DB >> 15225607

Serine protease inhibitor 2A inhibits caspase-independent cell death.

Ni Liu1, Yue Wang, Philip G Ashton-Rickardt.   

Abstract

The release of cysteine cathepsins from the lysosome into the cytoplasm can trigger programs of cell death (PCD) that do not require caspase executioner proteases but instead are mediated by toxic reactive oxygen species (ROS). Here, we show that a cytoplasmic inhibitor of papain-like cathepsins - Serine protease inhibitor 2A (Spi2A) - is required for the protection of cells from caspase-independent PCD triggered by tumor necrosis factor-alpha. In the absence of caspase activity, Spi2A suppressed PCD by inhibiting cathepsin B after it was released into the cytoplasm. Spi2A also directly protected against ROS-mediated PCD, which is consistent with a role in suppressing caspase-independent pathways of PCD. We conclude that inhibition of lysosomal executioner proteases by Spi2A is a physiological mechanism by which cells are protected from caspase-independent programmed cell death.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15225607     DOI: 10.1016/j.febslet.2004.05.061

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

Review 1.  Erythropoietin receptor response circuits.

Authors:  Don M Wojchowski; Pradeep Sathyanarayana; Arvind Dev
Journal:  Curr Opin Hematol       Date:  2010-05       Impact factor: 3.284

2.  Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells.

Authors:  Chance John Luckey; Deepta Bhattacharya; Ananda W Goldrath; Irving L Weissman; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

Review 3.  Intrinsic and extrinsic control of effector T cell survival and memory T cell development.

Authors:  Timothy W Hand; Susan M Kaech
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

Review 4.  Endolysosomal proteases and their inhibitors in immunity.

Authors:  Phillip I Bird; Joseph A Trapani; José A Villadangos
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

5.  Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis.

Authors:  Kenji Ishitsuka; Teru Hideshima; Makoto Hamasaki; Noopur Raje; Shaji Kumar; Hiromasa Hideshima; Norihiko Shiraishi; Hiroshi Yasui; Aldo M Roccaro; Paul Richardson; Klaus Podar; Steven Le Gouill; Dharminder Chauhan; Kazuo Tamura; Jack Arbiser; Kenneth C Anderson
Journal:  Blood       Date:  2005-05-03       Impact factor: 22.113

6.  EPO receptor circuits for primary erythroblast survival.

Authors:  Pradeep Sathyanarayana; Arvind Dev; Jing Fang; Estelle Houde; Olga Bogacheva; Oleg Bogachev; Madhu Menon; Sarah Browne; Anamika Pradeep; Christine Emerson; Don M Wojchowski
Journal:  Blood       Date:  2008-03-18       Impact factor: 22.113

7.  Comparative Analyses of Transcriptional Profiles in Mouse Organs Using a Pneumonic Plague Model after Infection with Wild-Type Yersinia pestis CO92 and Its Braun Lipoprotein Mutant.

Authors:  Cristi L Galindo; Scott T Moen; Elena V Kozlova; Jian Sha; Harold R Garner; Stacy L Agar; Ashok K Chopra
Journal:  Comp Funct Genomics       Date:  2010-01-20

8.  Hepatic gene expression profile in mice perorally infected with Echinococcus multilocularis eggs.

Authors:  Bruno Gottstein; Matthias Wittwer; Marc Schild; Michael Merli; Stephen L Leib; Norbert Müller; Joachim Müller; Rolf Jaggi
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

9.  Gene expression programs of mouse endothelial cells in kidney development and disease.

Authors:  Eric W Brunskill; S Steven Potter
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

10.  Identification and characterization of a serine protease inhibitor of Paragonimus westermani.

Authors:  Jin-Hee Hwang; Wook-Gyo Lee; Byoung-Kuk Na; Hyeong-Woo Lee; Shin-Hyeong Cho; Tong-Soo Kim
Journal:  Parasitol Res       Date:  2008-10-17       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.